Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H26N2O2 |
Molecular Weight | 290.4005 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNCCCC(C#N)(C(C)C)C1=CC(OC)=C(OC)C=C1
InChI
InChIKey=WLOBUUJURNEQCL-UHFFFAOYSA-N
InChI=1S/C17H26N2O2/c1-13(2)17(12-18,9-6-10-19-3)14-7-8-15(20-4)16(11-14)21-5/h7-8,11,13,19H,6,9-10H2,1-5H3
Molecular Formula | C17H26N2O2 |
Molecular Weight | 290.4005 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Verapamil: metabolism in cultures of primary human coronary arterial endothelial cells. | 2003 Jul |
|
Aerobic biodegradability of the calcium channel antagonist verapamil and identification of a microbial dead-end transformation product studied by LC-MS/MS. | 2008 Jun |
|
Synthesis and preclinical evaluation of [11C]D617, a metabolite of (R)-[11C]verapamil. | 2012 May |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:22:15 GMT 2023
by
admin
on
Sat Dec 16 11:22:15 GMT 2023
|
Record UNII |
L49D7PR96D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
L49D7PR96D
Created by
admin on Sat Dec 16 11:22:16 GMT 2023 , Edited by admin on Sat Dec 16 11:22:16 GMT 2023
|
PRIMARY | |||
|
251-895-1
Created by
admin on Sat Dec 16 11:22:16 GMT 2023 , Edited by admin on Sat Dec 16 11:22:16 GMT 2023
|
PRIMARY | |||
|
DTXSID40891459
Created by
admin on Sat Dec 16 11:22:16 GMT 2023 , Edited by admin on Sat Dec 16 11:22:16 GMT 2023
|
PRIMARY | |||
|
93168
Created by
admin on Sat Dec 16 11:22:16 GMT 2023 , Edited by admin on Sat Dec 16 11:22:16 GMT 2023
|
PRIMARY | |||
|
34245-14-2
Created by
admin on Sat Dec 16 11:22:16 GMT 2023 , Edited by admin on Sat Dec 16 11:22:16 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
ENANTIOMER -> RACEMATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
22% 0f dose
MAJOR
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|